Pharmasaga Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	211.03	21.87	154.64	36.73
Short-Term Investments	350.03	156.86	-	-
Cash & Short-Term Investments	561.05	178.73	154.64	36.73
Cash Growth	1427.43%	15.58%	320.99%	-
Other Receivables	1.83	0.02	0.06	-
Receivables	1.83	0.02	0.06	-
Prepaid Expenses	5.24	3.62	0.95	0.07
Other Current Assets	-	0.22	-	-
Total Current Assets	568.13	182.59	155.65	36.81
Property, Plant & Equipment	4.89	0.27	-	-
Other Intangible Assets	71.9	75.47	82.34	89.39
Other Long-Term Assets	17.07	16.82	0.09	0.03
Total Assets	661.98	275.15	238.08	126.23
Accrued Expenses	12	13.31	6.57	0.19
Current Portion of Leases	0.68	0.26	-	-
Other Current Liabilities	0.15	0.45	0.38	0.01
Total Current Liabilities	12.83	14.02	6.95	0.19
Total Liabilities	15.63	14.02	6.95	0.19
Common Stock	357.01	282.01	126.47	126.47
Additional Paid-In Capital	-	60	13.33	13.33
Retained Earnings	-27.28	-80.88	-41.19	-13.76
Comprehensive Income & Other	316.62	-	132.52	-
Shareholders' Equity	646.35	261.13	231.13	126.04
Total Liabilities & Equity	661.98	275.15	238.08	126.23
Total Debt	3.49	0.26	-	-
Net Cash (Debt)	557.57	178.47	154.64	36.73
Net Cash Growth	1417.94%	15.41%	320.99%	-
Net Cash Per Share	17.72	7.16	7.12	1.90
Filing Date Shares Outstanding	35.7	28.2	12.65	19.29
Total Common Shares Outstanding	35.7	28.2	12.65	19.29
Working Capital	555.3	168.57	148.7	36.62
Book Value Per Share	18.10	9.26	18.28	6.53
Tangible Book Value	574.45	185.66	148.79	36.65
Tangible Book Value Per Share	16.09	6.58	11.77	1.90

Source: S&P Global Market Intelligence. Standard template. Financial Sources.